Pharmacogenomics

The Indian Health Service is forecasting a pilot project to establish a send-out laboratory for pharmacogenomic capabilities under a Total Small Business Set-Aside, with the NAICS code 541380 indicating it pertains to other scientific and technical consulting services. This initiative aims to enhance personalized medicine efforts by leveraging genetic information to guide medication selection and dosing for patients, particularly within Native American and Alaska Native communities served by the agency. The project is designed as a pilot, suggesting it is an initial phase intended to evaluate feasibility, outcomes, and scalability of outsourcing pharmacogenomic testing to qualified laboratories. Contracting for this opportunity is reserved exclusively for small businesses, and all inquiries or proposals must be submitted by entities meeting SBA size standards. The point of contact for program-related questions is Cynthia Gunderson, while Karen McDonald serves as the contracting officer, providing the official channel for procurement matters. Although specific details such as funding amounts, performance locations, and timelines are not included in the forecast, the opportunity will likely require vendors to demonstrate expertise in clinical laboratory services, compliance with regulatory standards for genetic testing, and experience working with federal health agencies. This initiative reflects a strategic move by the Indian Health Service to integrate advanced genomic technologies into its healthcare delivery model to improve patient outcomes.